Mottiwala Aziz (CIK 0001788542)

Latest company ownership

TARS - Tarsus Pharmaceuticals, Inc.

Role: Chief Commercial Officer

Shares held

47,557

Last filed at

Jun 11, 2025

Confidence Score

48.0

2025Q4

Confidence Score History

2021Q3 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Jun 9, 2025	Jun 11, 2025	Tarsus Pharmaceuticals, Inc.	Chief Commercial Officer	Sell	7.5	-17,500	-26.90%	✓	$765.8K
Mar 18, 2025	Mar 20, 2025	Tarsus Pharmaceuticals, Inc.	Chief Commercial Officer	Sell	40.0	-10,565	-13.97%	✗	$505.9K
Mar 15, 2024	Mar 19, 2024	Tarsus Pharmaceuticals, Inc.	Chief Commercial Officer	Sell	42.5	-4,766	-8.10%	✗	$145.8K
Jul 19, 2023	Jul 21, 2023	Tarsus Pharmaceuticals, Inc.	Chief Commercial Officer	Sell	41.3	-2,400	-4.98%	✓	$48.1K
Jun 8, 2023	Jun 12, 2023	Tarsus Pharmaceuticals, Inc.	Chief Commercial Officer	Sell	55.0	-100	-0.21%	✓	$2K
Jun 6, 2023	Jun 8, 2023	Tarsus Pharmaceuticals, Inc.	Chief Commercial Officer	Sell	28.8	-4,643	-8.79%	✓	$88.2K
Mar 21, 2023	Mar 23, 2023	Tarsus Pharmaceuticals, Inc.	Chief Commercial Officer	Sell	46.3	-1,078	-2.00%	✗	$13.5K
Mar 17, 2023	Mar 21, 2023	Tarsus Pharmaceuticals, Inc.	Chief Commercial Officer	Sell	47.5	-697	-1.28%	✗	$9K
Mar 15, 2023	Mar 17, 2023	Tarsus Pharmaceuticals, Inc.	Chief Commercial Officer	Sell	50.0	-336	-0.61%	✗	$4.5K
Nov 15, 2022	Nov 17, 2022	Tarsus Pharmaceuticals, Inc.	Chief Commercial Officer	Sell	25.0	-6,857	-12.12%	✓	$121.5K
Nov 8, 2021	Nov 10, 2021	Tarsus Pharmaceuticals, Inc.	Chief Commercial Officer	Sell	37.5	-1,889	-3.63%	✓	$53.1K
Nov 4, 2021	Nov 8, 2021	Tarsus Pharmaceuticals, Inc.	Chief Commercial Officer	Sell	55.0	-111	-0.21%	✓	$3.1K
Nov 2, 2021	Nov 4, 2021	Tarsus Pharmaceuticals, Inc.	Chief Commercial Officer	Sell	25.0	-6,000	-10.31%	✓	$160.7K
Sep 10, 2021	Sep 14, 2021	Tarsus Pharmaceuticals, Inc.	Chief Commercial Officer	Sell	22.5	-2,593	-4.27%	✗	$57.4K